Dyax Wins Positive Opinion for European Orphan Designation
Dyax announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion recommending DX-2930.
All Work
Chris Lange
Civitas Readies for Secondary Offering
Selling stockholders are offering 3 million Civitas Solutions shares in a secondary offering valued up to more than $84 million.
Why Western Digital’s Massive Investment From China Pleases Investors
ThinkstockChinese companies are continuing to make moves within the American tech sector, and the most recent target is Western Digital Corp. (NASDAQ: WDC). In a move that gave shares a much needed bump from…
Why Sanchez Energy and Bill Barrett Shares Could More Than Double
Oil has been absolutely beaten up over the past year, and that has resulted in the awful treatment of speculative companies within the industry.
Dave & Buster’s Gears Up for Secondary Offering
Dave & Buster's Entertainment will not receive any proceeds from the offering valued at up to $270.1 million.
Why Oppenheimer Sees Even More Good News from Amazon Web Services Driving the Stock
Amazon.com is set to host its Amazon Web Services re:Invent Conference in Las Vegas, and one key analyst is giving us the inside track on what to expect.
Costco Up on Mixed Q4 Earnings
Costco Wholesale reported mixed fiscal fourth-quarter financial results after the markets closed on Tuesday.
Ceres Scores With Licensing Agreement
Ceres announced that KWS SAAT SE, a global seed developer with operations in over 70 counties, will evaluate its Persephone bioinformatics technology under a license agreement.
Phoenix Hits It Big With Buyout Agreement
Phoenix Companies made waves in the market on Tuesday afternoon as one of the biggest winners on the day from some M&A action.
CytomX Therapeutics Sets Terms for IPO
More than 6 million CytomX shares are expected to price in the range of $14 to $16 in an IPO valued up to more than $122 million.
Why Oppenheimer Sees Community Health Worth Almost Twice as Much
Despite a declining health care sector of late, one key analyst sees potential in Community Health Systems.
Key Analyst Sees Opportunity in Diagnostics Sell-Off
The unexpected reimbursement rate proposals by the Center for Medicaid hit the diagnostic sector on Monday.
Digital Turbine Prepares for Secondary Offering
Digital Turbine has announced the pricing of its public offering of 7.6 million shares of common stock to the public.
Consumer Confidence Shocks Analysts
The Conference Board released a number for consumer confidence in September that was a big surprise to most.
Novavax Rekindles Positive Momentum With RSV and Gates Grant
Novavax has announced positive top-line data from a Phase 2 clinical trial of its RSV F-protein recombinant nanoparticle vaccine candidate to protect infants via maternal immunization.
Esperion Update Not Enough for Investors
Esperion plans to conduct multiple Phase 3 clinical trials that will separately evaluate patients with statin intolerance.
Chipotle Puts Carnitas Back on the Menu
Chipotle Mexican Grill has announced that it has restored most of its pork supply and is again serving carnitas in 90% of its restaurants.
What to Expect From Costco Earnings
Wikimedia CommonsCostco Wholesale Corp. (NASDAQ: COST) is scheduled to report its fiscal fourth quarter financial results after the markets close on Tuesday. The consensus estimates from Thomson Reuters call for $1.66 in earnings per…
Why Nomura Is Optimistic on American Express
After meeting with management of American Express, Nomura walked away feeling greater confidence in the underlying strength of the company's core franchise.
Is Carl Icahn for the Bears With This New Video?
Carl Icahn has released an ominous video on his website saying that the seven-year bull market has run its course.